All times are in Japan Local Time.
Program is subject to change.
| Time | Session | Location | People |
|---|---|---|---|
| 8:30-9:00 AM | Registration / Breakfast | TBD | |
| 9:00 AM-12:30 PM | Short Course 2: Decentralized Clinical Trials: Design, Conduct, and Analysis in the Digital Era | TBD | Instructors: Jie Chen, PhD, Taimei Intelligence Biopharma R&D Ltd.; Feinan Lu, IMPACT Therapeutics |
| 9:00 AM-5:00 PM | Short Course 1: Bayesian Statistics and Bayesian Models for Practical Dose Finding and Dose Optimization Oncology Clinical Trials | TBD | Instructors: Ying Lu, PhD, Stanford University; Yuan Ji, PhD, The University of Chicago; Dehua Bi, PhD, Stanford Cancer Institute |
| 12:30-1:30 PM | Lunch for all courses | TBD | |
| 1:30-5:00 PM | Short Course 3: Advances in Causal Generative Medical AI | TBD | Instructor: Hongtu Zhu |
| Time | Session | Location | People |
|---|---|---|---|
| 8:30-9:00 AM | Registration and Breakfast | TBD | |
| 9:00-9:10 AM | Opening Remark | TBD |
Yuan Ji, PhD, UChicago Satoshi Hattori, PhD, Osaka |
| 9:10-10:00 AM | Keynote Session 1: Oncology Keynote | TBD |
Speaker: Kan Yonemori, MD, PhD, NCCH Moderator: Shivaani Kummar, MD, OHSU |
| 10:00-10:15 AM | Break (Poster Session 1) | TBD | |
| 10:15-11:45 AM | Invited Session 1: Advancing platform trials in oncology | TBD | |
| 10:15-11:45 AM | Invited Session 2: Treatment switching in oncology trials | TBD | |
| 11:45 AM-12:45 PM | Lunch (Poster Session 1) | TBD | |
| 12:45-1:35 PM | Keynote Session 2: Clinical Trial Keynote | TBD |
Speaker: Marc Buyse, ScD, University of Hasselt Moderator: Susan Halabi, PhD, Duke |
| 1:35-1:50 PM | Break (Poster Session 1) | TBD | |
| 1:50-3:20 PM | Plenary Session 1: Panel discussion on modern statistical frameworks for pediatric oncology and rare disease clinical trials | TBD |
Organizers: Haitao Pan, PhD, St. Jude; Yuan Ji, PhD, UChicago Panelists: Elizabeth Fox, MD, St. Jude; Kentaro Takeda, PhD, Astellas; Vicky Qian Wu, PhD, Fred Hutch; Luyan Dai, PhD, G-Plume Group |
| 3:20-3:35 PM | Break (Poster Session 1) | TBD | |
| 3:35-5:05 PM | Invited Session 3: Dose optimization | TBD | |
| 3:35-5:05 PM | Invited Session 4: Data Science in Oncology: From Data to Clinical Impact | TBD |
Moderator: Chao Agnes Hsiung, PhD, National Health Research Institutes, Taiwan Speakers: Takashi Kohno, PhD, National Cancer Center, Japan; Kouya Shiraishi, PhD, National Cancer Center Research Institute, Japan; I-Shou Chang, PhD, National Health Research Institutes, Taiwan; Chao-Hua Chiu, MD, Taipei Medical University Hospital, Taiwan |
| 5:05-5:45 PM | Break (Poster Session 1) | TBD | |
| 5:45-8:45 PM | Banquet | TBD |
| Time | Session | Location | People |
|---|---|---|---|
| 8:30-9:00 AM | Registration and Breakfast | TBD | |
| 9:00-9:50 AM | Keynote Session 3: Bioinformatics/AI Keynote | TBD |
Speaker: Hongyu Zhao, PhD, Yale Moderator: Shannon McWeeney, PhD, OU |
| 9:50-10:05 AM | Break (Poster Session 2) | TBD | |
| 10:05-11:35 AM | Invited Session 5: Emerging trends in oncology drug development - regulatory, statistical, and clinical perspectives | TBD |
Moderator: Toshimitsu Hamasaki, PhD, GWU Speakers: Toyotake Iguchi, MD, PhD, NHRI; Tzy-Chy Lin, MD, PhD, Taiwan CDE; Shunsuke Shiota, MMSc, PMDA; Kenichi Nakamura, MD, PhD, NCC Japan |
| 10:05-11:35 AM | Invited Session 6: From data to evidence - statistical learning and AI methods for oncology trials | TBD |
Moderator: Wei Wei, PhD, Yale Speakers: Ruitao Lin, PhD, MD Anderson; Shouhao Zhou, PhD, Penn State; Yanxun Xu, PhD, JHU; Arsela Prelaj, MD, ESMO; Ravi Parikh, MD, Emory |
| 11:35 AM-12:35 PM | Lunch (Poster Session 2) | TBD | |
| 12:35-1:25 PM | Keynote Session 4: Regulatory Keynote | TBD |
Speaker: Yasuhiro Fujiwara, MD, PhD, PMDA Moderator: Hajime Uno, PhD, Harvard |
| 1:25-1:40 PM | Break (Poster Session 2) | TBD | |
| 1:40-3:10 PM | Invited Session 7: Development of AI-powered prognostic and predictive biomarkers to guide treatment | TBD | |
| 1:40-3:10 PM | Invited Session 8: Rapid talks | TBD |
Moderator: Byung Park, PhD, OHSU Reserved for sponsors and poster winners |
| 3:10-3:25 PM | Break (Poster Session 2) | TBD | |
| 3:25-4:50 PM | Plenary Session 2: Panel discussion on new regulatory guidelines on RWD, rare disease, biomarker, and Bayesian statistical methods | TBD | |
| 4:50-5:00 PM | Closing Remarks | TBD |
| Time | Session | Location | People |
|---|---|---|---|
| 8:30-9:00 AM | Registration / Breakfast | TBD | |
| 9:00 AM-12:30 PM | Short Course 5: Biomarker-Driven Trials for Precision Oncology | TBD | Instructors: Susan Halabi; Junki Mizusawa |
| 9:00 AM-5:00 PM | Short Course 4: Beyond the Hazard Ratio: RMST and Other Measures for Survival Analysis | TBD | Instructors: Lu Tian, Stanford University; Hajime Uno, Harvard Medical School and Dana-Farber Cancer Institute |
| 12:30-1:00 PM | Lunch for all courses | TBD | |
| 1:00-4:00 PM | Short Course 6: Statistical Methods Addressing Treatment Switching in Oncology Trials | TBD | Instructors: Ray Lin, PhD, ASA Biopharmaceutical Section and Chang Gung University; Shingo Kuroda, Takeda; Shuji Sumino, Takeda; Tadayuki Kitagawa, Takeda; Xiaolin Song, PhD, Takeda |